Lithotritie stéréotaxique. Système de localisation "Freeline". Un système sans contrainte pour garantir le traitement le plus efficace. Disponible sur toute la gamme Sonolith®.
Focal One® répond à tous les critères pour une thérapie focale idéale : fusion d'images IRM, approche chirurgicale non-invasive, énergie thérapeutique précise et efficace et validation de la zone traitée par IRM le lendemain du traitement.
EDAP Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis
Read more
EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. This reimbursement took effect on July 1, 2023.
Read more
Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer
Read more
EDAP TMS SA, a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT).
Read more
EDAP TMS, un des leaders mondiaux sur la lithotritie extracorporelle, propose une gamme complète de solutions non-invasives et mini-invasives qui couvre toute l'étendue des indications du calcul urinaire.
EDAP TMS propose une alternative aux thérapies radicales standard telles que la chirurgie ou la radiothérapie, non-invasive et basée sur les ultrasons focalisés ...